Maven Securities »

Terns Pharmaceuticals shares owned by Maven Securities

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 30k 40.40

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Terns Pharmaceuticals

BlackRock
Vanguard Group
Vivo Capital
Vestal Point Capital
Adage Capital Partners GP
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
OrbiMed Advisors
Geode Capital Management
Ameriprise Financial
State Street Corporation
Acorn Capital Advisors
Nearwater Capital Markets
Citadel Advisors

View all funds holding Terns Pharmaceuticals